Atreca's Series C Round

Atreca raised a round of funding on September 12, 2018.

Atreca is a privately held biotechnology company developing therapeutics drawn from human immune responses, including effective anti-cancer immune responses. The company is able to measure and analyze…

Articles about Atreca's Series C Round: